Yarona Healthcare Network (Pty) Ltd v Medshield Medical Scheme

Medshield, a medical scheme registered under the Medical Schemes Act 131 of 1998, made 20 payments to Yarona Healthcare Network totaling R6,110,237 over the period 6 August 2007 to 17 July 2009. The payments were made based on monthly invoices for services described as 'healthcare provider research and geo-mapping'. Yarona initially defended the action claiming the payments were made pursuant to a valid service agreement concluded in June 2007. However, on 26 February 2015, Yarona conceded that it could not prove that the persons who purportedly represented Medshield had authority to conclude the agreement. The payments were facilitated by Clinton Alley, Medshield's principal officer, who approved invoices and payment instructions without proper board authorization. In 2009, following Alley's suspension for suspicious payments, Medshield discovered the extent of unauthorized payments. The scheme sued for recovery by way of condictio indebiti. Yarona raised defenses of inexcusable slackness and prescription in respect of payments made before 7 June 2008.

• Whether Medshield's mistakes in making the payments were inexcusably slack, thereby barring recovery via condictio indebiti
• Whether excusability is a requirement for recovery by a medical scheme in the circumstances
• Whether Medshield proved its impoverishment despite having received some benefits from Yarona's networks
• Whether prescription had commenced running by 7 June 2008 (three years before summons) based on knowledge of the board of trustees
• What knowledge (actual or constructive) is required for prescription to commence running, and whose knowledge must be attributed to a medical scheme

The appeal was dismissed with costs including the costs of two counsel. The High Court's judgment in favor of Medshield for R6,110,237 was upheld.

1. Excusability is not a requirement for recovery via condictio indebiti by a medical scheme. The exception recognized in Bowman for executors, liquidators and trustees extends to medical schemes because scheme administrators act in a representative capacity for vulnerable members and owe them fiduciary duties. 2. In cases of bilateral performance under putative contracts, impoverishment is established when the plaintiff suffers loss in making the payment. If the defendant conferred benefits on the plaintiff, the defendant's proper remedy is to counterclaim via condictio indebiti, not to raise the plaintiff's enrichment as a defense to the impoverishment element. 3. For prescription purposes, when a medical scheme brings a claim, the requisite actual or constructive knowledge that must exist before prescription begins to run is that of the board of trustees (in the absence of evidence that authority to litigate was delegated). 4. Authorizing payments without verifying the existence of a validly concluded contract, particularly where the scheme requires board approval for contracts and dual signatories for payments, constitutes inexcusably slack conduct.

1. The court observed that there is no logical distinction between mistakes of fact and mistakes of law in the context of condictio indebiti (following Willis Faber). 2. The court noted that although restitutio in integrum is not an enrichment action, it is often confused with the condictiones. 3. Rogers AJA discussed German law approaches to unwinding void mutual contracts, including the Zweikondiktionentheorie (two-claims theory), Saldotheorie (balance theory), and modifizierte Zweikondiktionentheorie (modified two-claims theory), but stated it was unnecessary to decide which modifications should apply in South African law, leaving this to be worked out on specific facts. 4. The court noted that if fraud had been properly pleaded against Yarona, this could have been relevant to the excusability inquiry, but emphasized that fraud must be specifically pleaded (citing Home Talk Developments v Ekurhuleni). 5. The court observed that a claim based on fraud or theft would have been an obvious alternative claim against Yarona if collusion with Alley could be proved. 6. The court commented that professional liquidators, trustees and executors who earn substantial fees and carry professional indemnity insurance have less need for protection than the rationale in Wessels suggested, indicating the policy focus should be on protecting beneficiaries rather than fiduciaries.

This case is significant in South African enrichment law for: (1) Extending the Bowman exception (relaxing the excusability requirement) to medical schemes, based on the vulnerable position of members and the representative nature of scheme administrators; (2) Clarifying that in bilateral performance cases under putative contracts, the proper procedure is for each party to counterclaim via condictio indebiti rather than raising loss of enrichment as a defense to impoverishment; (3) Confirming that for prescription purposes in claims by corporate bodies like medical schemes, the relevant knowledge is that of the board of trustees (absent delegation of authority to litigate); (4) Emphasizing that office bearers of medical schemes owe fiduciary duties to members and that policy considerations favor protecting vulnerable members' interests in the context of healthcare funding; (5) Providing detailed analysis of what constitutes inexcusably slack conduct in payment authorization processes.